WallStSmart

AbbVie Inc (ABBV)vsRestaurant Brands International Inc (QSR)

VS

Smart Verdict

WallStSmart Research — data-driven comparison

AbbVie Inc generates 555% more annual revenue ($62.82B vs $9.59B). QSR leads profitability with a 10.0% profit margin vs 5.8%. ABBV appears more attractively valued with a PEG of 0.57. QSR earns a higher WallStSmart Score of 70/100 (B).

ABBV

Buy

63

out of 100

Grade: C+

Growth: 4.0Profit: 8.0Value: 4.0Quality: 5.0
Piotroski: 5/9Altman Z: 0.40

QSR

Strong Buy

70

out of 100

Grade: B

Growth: 8.0Profit: 8.0Value: 8.0Quality: 4.3
Piotroski: 4/9Altman Z: 0.93
IV

Intrinsic Value Comparison

Multi-model valuation · Graham Formula

ABBVSignificantly Overvalued (-19.7%)

Margin of Safety

-19.7%

Fair Value

$168.33

Current Price

$201.55

$33.22 premium

UndervaluedFair: $168.33Overvalued
QSRUndervalued (+33.6%)

Margin of Safety

+33.6%

Fair Value

$106.48

Current Price

$79.71

$26.77 discount

UndervaluedFair: $106.48Overvalued

Key Strengths & Concerns

Side-by-side fundamental analysis

Key Strengths

ABBV5 strengths · Avg: 9.6/10
Market CapQuality
$358.55B10/10

Mega-cap, among the largest globally

Return on EquityProfitability
62.3%10/10

Every $100 of equity generates 62 in profit

Operating MarginProfitability
31.6%10/10

Strong operational efficiency at 31.6%

Debt/EquityHealth
-21.0610/10

Conservative balance sheet, low leverage

PEG RatioValuation
0.578/10

Growing faster than its price suggests

QSR4 strengths · Avg: 8.8/10
EPS GrowthGrowth
100.0%10/10

Earnings expanding 100.0% YoY

Return on EquityProfitability
28.1%9/10

Every $100 of equity generates 28 in profit

PEG RatioValuation
0.948/10

Growing faster than its price suggests

Operating MarginProfitability
27.0%8/10

Strong operational efficiency at 27.0%

Areas to Watch

ABBV4 concerns · Avg: 2.3/10
Profit MarginProfitability
5.8%3/10

5.8% margin — thin

P/E RatioValuation
98.9x2/10

Premium valuation, high expectations priced in

EPS GrowthGrowth
-45.8%2/10

Earnings declined 45.8%

Altman Z-ScoreHealth
0.402/10

Distress zone — elevated risk

QSR2 concerns · Avg: 3.0/10
P/E RatioValuation
25.4x4/10

Moderate valuation

Altman Z-ScoreHealth
0.932/10

Distress zone — elevated risk

Comparative Analysis Report

WallStSmart Research

Bull Case : ABBV

The strongest argument for ABBV centers on Market Cap, Return on Equity, Operating Margin. Revenue growth of 12.4% demonstrates continued momentum. PEG of 0.57 suggests the stock is reasonably priced for its growth.

Bull Case : QSR

The strongest argument for QSR centers on EPS Growth, Return on Equity, PEG Ratio. PEG of 0.94 suggests the stock is reasonably priced for its growth.

Bear Case : ABBV

The primary concerns for ABBV are Profit Margin, P/E Ratio, EPS Growth. A P/E of 98.9x leaves little room for execution misses.

Bear Case : QSR

The primary concerns for QSR are P/E Ratio, Altman Z-Score.

Key Dynamics to Monitor

QSR carries more volatility with a beta of 0.55 — expect wider price swings.

ABBV is growing revenue faster at 12.4% — sustainability is the question.

Monitor DRUG MANUFACTURERS - GENERAL industry trends, competitive dynamics, and regulatory changes.

Bottom Line

QSR scores higher overall (70/100 vs 63/100). Both earn "Strong Buy" and "Buy" ratings respectively — the choice depends on your investment horizon and risk tolerance.

This analysis is generated from publicly available financial data. Not financial advice.

AbbVie Inc

HEALTHCARE · DRUG MANUFACTURERS - GENERAL · USA

AbbVie is an American publicly traded biopharmaceutical company founded in 2013. It originated as a spin-off of Abbott Laboratories.

Restaurant Brands International Inc

CONSUMER CYCLICAL · RESTAURANTS · USA

Restaurant Brands International Inc. owns, operates and franchises quick-service restaurants under the Tim Hortons (TH), Burger King (BK) and Popeyes (PLK) brands. The company is headquartered in Toronto, Canada.

Want to dig deeper into these stocks?